Zaptec ASA (OSL:ZAP)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,116	955	1,905	1,643	4,600	3,301
Market Cap Growth	-4.51%	-49.88%	15.92%	-64.28%	39.36%	-
Enterprise Value	2,134	1,061	1,754	1,466	4,386	3,294
Last Close Price	24.20	10.93	21.78	21.58	60.25	44.40
PE Ratio	-	-	85.69	-	101.09	187.61
Forward PE	42.85	22.46	15.22	15.70	52.82	149.24
PS Ratio	1.61	0.75	1.36	2.23	9.41	15.02
PB Ratio	3.17	1.41	2.87	5.06	11.66	10.71
P/TBV Ratio	4.38	1.63	3.35	7.04	15.02	11.12
P/FCF Ratio	18.25	-	-	-	95.61	-
P/OCF Ratio	17.67	-	-	-	87.48	225.78
EV/Sales Ratio	1.62	0.84	1.25	1.99	8.97	14.99
EV/EBITDA Ratio	35.50	31.37	69.96	-	65.59	195.21
EV/EBIT Ratio	56.56	49.77	132.79	-	70.18	273.56
EV/FCF Ratio	18.41	-	-	-	91.17	-
Debt / Equity Ratio	0.26	0.30	0.08	0.14	0.05	0.03
Debt / EBITDA Ratio	2.88	4.61	1.54	-	0.27	0.45
Debt / FCF Ratio	1.49	-	-	-	0.40	-
Asset Turnover	1.08	1.07	1.58	1.25	1.06	0.96
Inventory Turnover	1.56	1.65	3.31	7.71	14.00	9.22
Quick Ratio	0.92	0.85	1.03	0.95	2.44	6.30
Current Ratio	2.34	2.17	2.43	1.70	2.75	6.59
Return on Equity (ROE)	-0.25%	-0.48%	4.49%	-14.71%	12.95%	9.81%
Return on Assets (ROA)	1.93%	1.12%	0.93%	-4.81%	8.45%	3.30%
Return on Capital (ROIC)	2.73%	1.67%	1.52%	-7.26%	10.71%	3.96%
Return on Capital Employed (ROCE)	4.80%	2.70%	1.70%	-	14.90%	3.80%
Earnings Yield	-0.08%	-0.34%	1.17%	-3.22%	0.99%	0.53%
FCF Yield	5.48%	-4.23%	-14.93%	-4.48%	1.05%	-0.07%
Buyback Yield / Dilution	0.45%	-1.92%	-12.65%	-0.74%	-1.99%	-50.18%

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.